Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examination

Laryngoscope

Volumn 123, Issue 11, 2013, Pages 2664-2669

  Rangaswamy, Balasubramanya ^a   Fardanesh, M Reza ^a   Genden, Eric M ^a   Park, Eunice E ^a   Fatterpekar, Girish ^a   Patel, Zara ^a   Kim, Jongho ^a   Som, Peter M ^a   Kostakoglu, Lale ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

computed tomography; F 18 fluorodeoxyglucose positron emission tomography; neck high resolution computed tomography; recurrent squamous cell cancer of the head and neck

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; IOPAMIDOL;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SCINTISCANNING; CANCER SURGERY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOSCOPY; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEALTH CARE QUALITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; INTERMETHOD COMPARISON; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MANDIBLE CANCER; MANDIBLE RESECTION; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; PATIENT CARE; PET SCANNER; PHYSICAL EXAMINATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SALVAGE THERAPY; SENSITIVITY AND SPECIFICITY;

COMPUTED TOMOGRAPHY; F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY; NECK HIGH-RESOLUTION COMPUTED TOMOGRAPHY; RECURRENT SQUAMOUS CELL CANCER OF THE HEAD AND NECK;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; ENDOSCOPY; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; PHYSICAL EXAMINATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, SPIRAL COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84886840108     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24077     Document Type: Article

References (32)

1. Salama JK, Vokes EE,. Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer. Semin Oncol 2008; 35: 251-261.
2. Haas I, Hauser U, Ganzer U,. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 2001; 258: 177-183.
3. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 571-578.
4. Leemans CR, Tiwari R, Nauta JJP, van der Waal DDS, Snow GB,. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 1994; 73: 187-190.
5. Pellitteri PK, Ferlito A, Rinaldo A, et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck 2006; 28: 166-175.
6. Janot F, de Raucourt D, Benhamou E, et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol 2008; 26: 5518-5523.
7. Scher RL, Esclamado RM,. Organ and function preservation: the role of surgery as the optimal primary modality or as salvage after chemoradiation failure. Semin Radiat Oncol 2009; 19: 17-23.
8. National Comprehensive Cancer Network. Clinical practice guidelines in oncology head and neck cancers V.2.2008. Available at: http://www.nccn.org/ professionals/physician-gls/PDF/head-and-neck.pdf. Accessed December 2, 2008.
9. Hermans R,. Posttreatment imaging in head and neck cancer. Eur J Radiol 2008; 66: 501-511.
10. Porceddu SV, Burmeister BH, Hicks RJ,. Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond. Hematol Oncol Clin North Am 2008; 22: 1221-1238.
11. Gandhi D, Falen S, McCartney W, et al. Value of 2-[18F]-fluoro-2-deoxy-D- glucose imaging with dual-head gamma camera in coincidence mode: comparison with computed tomography/magnetic resonance imaging in patients with suspected recurrent head and neck cancers. J Comput Assist Tomogr 2005; 29: 513-519.
12. van den Broek GB, Rasch CR, Pameijer FA, Peter E, van den Brekel MW, Balm AJ,. Response measurement after intraarterial chemoradiation in advanced head and neck carcinoma: magnetic resonance imaging and evaluation under general anesthesia? Cancer 2006; 106: 1722-1729.
13. Hermans R, Pameijer FA, Mancuso AA, Parsons JT, Mendenhall WM,. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone? Radiology 2000; 214: 683-687.
14. Abdel Razek AA, Kandeel AY, Soliman N, et al. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 2007; 28: 1146-1152.
15. Vandecaveye V, De Keyzer F, Nuyts S, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007; 67: 960-971.
16. Adams S, Baum RP, Stuckensen T, Bitter K, Hor G,. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998; 25: 1255-1260.
17. Braams JW, Pruim J, Freling NJ, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995; 36: 211-216.
18. McGuirt WF, Williams DW 3rd, Keyes JW Jr, et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995; 105: 373-375.
19. Hanasono MM, Kunda LD, Segall GM, Ku GH, Terris DJ,. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999; 109: 880-885.
20. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 4: 1369-1379.
21. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM,. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004; 231: 65-72.
22. Branstetter BF 4th, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005; 235: 580-586.
23. Fakhry N, Lussato D, Jacob T, Giorgi R, Giovanni A, Zanaret M,. Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications. Eur Arch Otorhinolaryngol 2007; 264: 531-538.
24. Chen AY, Vilaseca I, Hudgins PA, Schuster D, Halkar R,. PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer? Head Neck 2006; 28: 487-495.
25. Inohara H, Enomoto K, Tomiyama Y, et al. The role of CT and (18)F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy. Acta Otolaryngol 2008; 7: 1-7.
26. Tan A, Adelstein DJ, Rybicki LA, et al. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2007; 133: 435-440.
27. Halpern BS, Yeom K, Fueger BJ, Lufkin RB, Czernin J, Allen-Auerbach M,. Evaluation of suspected local recurrence in head and neck cancer: a comparison between PET and PET/CT for biopsy proven lesions. Eur J Radiol 2007; 62: 199-204.
28. Shankar LK, Hoffman JM, Bacharach S, et al. National Cancer Institute. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med 2006; 47: 1059-1066.
29. Goodwin WJ Jr,. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000; 110 (Suppl 93): 1-18.
30. Jeong WJ, Jung YH, Kwon SK, et al. Role of surgical salvage for regional recurrence in laryngeal cancer. Laryngoscope 2007; 117: 74-77.
31. Gupta T, Master Z, Kannan S, et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur Nucl Med Mol Imaging 2011; 38: 2083-2095.
32. Zundel MT, Michel MA, Schultz CJ, et al. Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011; 81: e825-e832.